The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Safety and efficacy of daratumumab use in patients with renal impairment and hemodialysis.
 
Mateusz Niewinski
No Relationships to Disclose
 
Jamie Chin-Hon
No Relationships to Disclose
 
Meredith Akerman
No Relationships to Disclose
 
Faith Davies
Employment - NYU Langone Medical Center; University of Arkansas for Medical Sciences
Honoraria - Abbvie; Amgen; Bristol-Myers Squibb; Celgene; GlaxoSmithKline; Janssen Oncology; Oncopeptides; Pfizer; Sanofi; Takeda
Consulting or Advisory Role - Abbvie; Amgen; Bristol-Myers Squibb; Celgene; GlaxoSmithKline; Janssen Oncology; Oncopeptides; Pfizer; Sanofi; Takeda
Research Funding - Celgene (Inst); Janssen (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Celgene; Janssen Oncology; Takeda
 
Gareth Morgan
Honoraria - BMS; Genentech; Janssen; Karyopharm Therapeutics; Sanofi; Takeda
Consulting or Advisory Role - GlaxoSmithKline; Takeda; Takeda
Travel, Accommodations, Expenses - BMS; Janssen
 
Marc Justin Braunstein
Consulting or Advisory Role - Amgen; AstraZeneca; Celgene; Celgene; Epizyme; Janssen; Janssen; Karyopharm Therapeutics; Morphosys; Pfizer; Takeda; Takeda; Verastem
Research Funding - Celgene/Bristol-Myers Squibb (Inst); Janssen (Inst); Janssen (Inst)
Travel, Accommodations, Expenses - Takeda